Your browser doesn't support javascript.
The Omicron BA.2.2.1 subvariant drove the wave of SARS-CoV-2 outbreak in Shanghai during spring 2022.
Ling, Yun; Lu, Gang; Liu, Feng; Tan, Yun; Xu, Xiaoguang; Wei, Dong; Xu, Jinkun; Wang, Shuai; Yu, Shuting; Jiang, Fangying; Zhang, Xinxin; Chen, Shuo; Wang, Shengyue; Fan, Xiaohong; Chen, Saijuan.
  • Ling Y; Shanghai Public Health Clinical Center, Fudan University, Shanghai, China.
  • Lu G; Shanghai Institute of Hematology, National Research Center for Translational Medicine, State Key Laboratory of Medical Genomics, Ruijin Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, China.
  • Liu F; Shanghai Institute of Hematology, National Research Center for Translational Medicine, State Key Laboratory of Medical Genomics, Ruijin Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, China.
  • Tan Y; Shanghai Institute of Hematology, National Research Center for Translational Medicine, State Key Laboratory of Medical Genomics, Ruijin Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, China.
  • Xu X; Shanghai Institute of Hematology, National Research Center for Translational Medicine, State Key Laboratory of Medical Genomics, Ruijin Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, China.
  • Wei D; Shanghai Public Health Clinical Center, Fudan University, Shanghai, China.
  • Xu J; Shanghai Immune Therapy Institute, Renji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
  • Wang S; Shanghai Institute of Hematology, National Research Center for Translational Medicine, State Key Laboratory of Medical Genomics, Ruijin Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, China.
  • Yu S; Shanghai Institute of Hematology, National Research Center for Translational Medicine, State Key Laboratory of Medical Genomics, Ruijin Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, China.
  • Jiang F; Shanghai Institute of Hematology, National Research Center for Translational Medicine, State Key Laboratory of Medical Genomics, Ruijin Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, China.
  • Zhang X; Department of Infectious Diseases, Research Laboratory of Clinical Virology, National Research Center for Translational Medicine, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China. zhangx@shsmu.edu.cn.
  • Chen S; Shanghai Immune Therapy Institute, Renji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China. shuochen@sjtu.edu.cn.
  • Wang S; Shanghai Institute of Hematology, National Research Center for Translational Medicine, State Key Laboratory of Medical Genomics, Ruijin Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, China. wsy12115@rjh.com.cn.
  • Fan X; Shanghai Public Health Clinical Center, Fudan University, Shanghai, China. fanxiaohong@shphc.org.cn.
  • Chen S; Shanghai Institute of Hematology, National Research Center for Translational Medicine, State Key Laboratory of Medical Genomics, Ruijin Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, China. sjchen@stn.sh.cn.
Cell Discov ; 8(1): 97, 2022 Sep 27.
Article in English | MEDLINE | ID: covidwho-2050339

Full text: Available Collection: International databases Database: MEDLINE Topics: Variants Language: English Journal: Cell Discov Year: 2022 Document Type: Article Affiliation country: S41421-022-00468-1

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Topics: Variants Language: English Journal: Cell Discov Year: 2022 Document Type: Article Affiliation country: S41421-022-00468-1